Cardiff Metropolitan University
45 - Actovegin as an Ergogenic Aid.pdf (338.74 kB)
Download file

Actovegin Equals to Performance Enhancing Drug Doping: Fact or Fiction?

Download (338.74 kB)
journal contribution
posted on 2022-12-20, 17:41 authored by Paul Y F Lee, Alvin P Kwan, Paul M. Smith, James Brock, Len Nokes

 Actovegin is a biological drug that has been used for the treatment of sports muscle injuries. Several in vitro studies have shed light on potential mechanisms of action and the drug has consistently demonstrated its potential to reduce return from injury time for muscle tears in elite athletes. Yet it was banned for a time under the International Olympic Committee (IOC) as a blood doping agent, this ban was based on presumptuous conclusions and subsequently lifted after no indisputable evidence could be provided. This editorial aims to provide readers with some of the key, objective facts relating to Actovegin and then based on this, will offer an infromed opinion on its role in sports medicine. We also hope to highlight the importance of evidence-based medicine, particularly in the volatile field of Sports Medicine, and the need for facts, not fiction 


Published in

Journal of Tissue Science & Engineering




  • VoR (Version of Record)


: Lee PYF, Kwan AP, Smith PM, Brock J, Nokes L (2016) 'Actovegin Equals to Performance Enhancing Drug Doping: Fact or Fiction?', Journal of Tissue Science Engineering 7: 179. doi:10.4172/2157-7552.1000179

Electronic ISSN


Cardiff Met Affiliation

  • Cardiff School of Sport and Health Sciences

Cardiff Met Authors

Paul M. Smith

Cardiff Met Research Centre/Group

  • High Performance

Copyright Holder

  • © The Authors


  • en

Usage metrics

    Applied Sport Science - Journal Articles